Pacific Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Pacific Biosciences of
PACB Stock  USD 1.38  0.11  7.38%   
Pacific Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pacific Biosciences' valuation are provided below:
Gross Profit
42.1 M
Market Capitalization
447.1 M
Enterprise Value Revenue
5.2714
Revenue
152.4 M
Earnings Share
(2.74)
We have found one hundred twenty available trending fundamental ratios for Pacific Biosciences, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Pacific Biosciences recent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 3.9 B. The current year's Enterprise Value is expected to grow to about 4.4 B

Pacific Biosciences Total Revenue

78.97 Million

Check Pacific Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacific Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 56 M, Interest Expense of 14.1 M or Total Revenue of 79 M, as well as many indicators such as Price To Sales Ratio of 3.1, Dividend Yield of 0.0 or PTB Ratio of 0.94. Pacific financial statements analysis is a perfect complement when working with Pacific Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Pacific Stock
Check out the analysis of Pacific Biosciences Correlation against competitors.

Pacific Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding302.8 M288.4 M140.6 M
Slightly volatile
Total Assets1.3 B1.3 B623.2 M
Slightly volatile
Short and Long Term Debt Total706.1 M672.4 M279.2 M
Slightly volatile
Other Current Liabilities24.9 M14.9 M24.9 M
Slightly volatile
Total Current Liabilities50.3 M66.3 M49.9 M
Slightly volatile
Other Liabilities2.8 M3 M20.8 M
Pretty Stable
Property Plant And Equipment Net36.4 M46.6 M36.2 M
Slightly volatile
Current Deferred Revenue11.4 M13.9 M10.9 M
Slightly volatile
Accounts Payable17.4 M16.6 M8.1 M
Slightly volatile
Cash52.6 M55.4 M102 M
Slightly volatile
Non Current Assets Total803 M764.8 M294 M
Slightly volatile
Non Currrent Assets Other11.4 M10.8 M5.5 M
Slightly volatile
Other Assets1.091.155.6 M
Pretty Stable
Cash And Short Term Investments291.2 M389.9 M275.9 M
Slightly volatile
Short Term Investments181.1 M334.6 M177.5 M
Slightly volatile
Liabilities And Stockholders Equity1.3 B1.3 B623.2 M
Slightly volatile
Non Current Liabilities Total721.9 M687.6 M311.2 M
Slightly volatile
Other Current Assets20.4 M19.5 M6 M
Slightly volatile
Other Stockholder Equity2.8 B2.7 B1.3 B
Slightly volatile
Total Liabilities791.5 M753.9 M362.3 M
Slightly volatile
Property Plant And Equipment Gross135 M128.5 M52.2 M
Slightly volatile
Total Current Assets332.1 M495.7 M317.4 M
Slightly volatile
Short Term Debt7.8 M10 M7.5 M
Slightly volatile
Property Plant Equipment98.2 M93.5 M39.9 M
Slightly volatile
Long Term Debt679.9 M647.5 M313.7 M
Slightly volatile
Net Receivables14.1 M27.5 M12.9 M
Slightly volatile
Common Stock Total Equity189 K198.9 K40.5 M
Slightly volatile
Inventory61.7 M58.8 M25 M
Slightly volatile
Common Stock279.3 K294 K83.3 M
Slightly volatile
Long Term Debt Total1.1 B1 B418 M
Slightly volatile
Deferred Long Term Liabilities11.9 M16.9 M11.9 M
Slightly volatile
Non Current Liabilities Other18.3 M19.2 M37.9 M
Slightly volatile
Capital Surpluse1.2 B2.3 B1.2 B
Slightly volatile
Short and Long Term Debt418.9 K441 K9.7 M
Slightly volatile
Net Invested Capital711.6 M1.2 B411.6 M
Slightly volatile
Net Working Capital468 M429.4 M273.9 M
Slightly volatile
Capital Stock236.5 K294 K183.8 K
Slightly volatile
Capital Lease Obligations34.9 M24.9 M44.3 M
Slightly volatile

Pacific Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization56 M53.4 M14 M
Slightly volatile
Total Revenue79 M154 M85.5 M
Slightly volatile
Gross Profit28.8 M37.3 M31.1 M
Slightly volatile
Other Operating Expenses537.2 M511.6 M245.2 M
Slightly volatile
Research Development89.8 M134.9 M83.4 M
Slightly volatile
Total Operating Expenses413.3 M393.7 M184.1 M
Slightly volatile
Cost Of Revenue70.2 M116.7 M58.4 M
Slightly volatile
Selling General Administrative87.6 M175 M80.1 M
Slightly volatile
Interest Income2.3 M2.3 M2.7 M
Slightly volatile
Reconciled Depreciation56 M53.4 M15.7 M
Slightly volatile
Non Recurring24.9 M28 M30.5 M
Slightly volatile

Pacific Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation74.6 M71 M33.2 M
Slightly volatile
Begin Period Cash Flow105.4 M182.6 M103.4 M
Slightly volatile
Depreciation56 M53.3 M14.4 M
Slightly volatile
Capital Expenditures6 M6.2 M5.5 M
Slightly volatile
End Period Cash Flow105.7 M55.4 M95 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.13.261524.8605
Slightly volatile
Days Sales Outstanding41.0965.229550.7217
Slightly volatile
Stock Based Compensation To Revenue0.440.46120.3621
Very volatile
Capex To Depreciation0.110.1160.7003
Slightly volatile
Inventory Turnover2.181.98682.6
Pretty Stable
Days Of Inventory On Hand162184156
Pretty Stable
Payables Turnover6.287.03637.54
Pretty Stable
Sales General And Administrative To Revenue0.880.931.9681
Slightly volatile
Research And Ddevelopement To Revenue0.830.8761.5459
Slightly volatile
Capex To Revenue0.03820.04020.1506
Slightly volatile
Cash Per Share1.351.420610.3696
Slightly volatile
Days Payables Outstanding55.4351.87452.7457
Slightly volatile
Income Quality0.890.6650.8085
Very volatile
Intangibles To Total Assets0.390.56120.4282
Slightly volatile
Current Ratio9.157.47647.841
Pretty Stable
Receivables Turnover9.195.59568.4034
Slightly volatile
Capex Per Share0.02140.02250.0502
Slightly volatile
Revenue Per Share0.50.56110.6457
Very volatile
Interest Debt Per Share2.622.49861.3548
Slightly volatile
Debt To Assets0.560.53350.2408
Slightly volatile
Graham Number2.282.572.7986
Slightly volatile
Operating Cycle151249186
Pretty Stable
Days Of Payables Outstanding55.4351.87452.7457
Slightly volatile
Long Term Debt To Capitalization0.590.5610.3249
Slightly volatile
Quick Ratio8.616.59027.2992
Pretty Stable
Net Income Per E B T0.711.0010.888
Slightly volatile
Cash Ratio0.790.83523.0466
Slightly volatile
Cash Conversion Cycle113197140
Pretty Stable
Days Of Inventory Outstanding162184156
Pretty Stable
Days Of Sales Outstanding41.0965.229550.7217
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.171.031.0661
Pretty Stable
Fixed Asset Turnover2.373.30533.2864
Pretty Stable
Debt Ratio0.560.53350.2408
Slightly volatile
Price Sales Ratio3.13.261524.8605
Slightly volatile
Asset Turnover0.220.12220.3083
Pretty Stable
Gross Profit Margin0.280.24210.349
Very volatile

Pacific Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.9 B3.7 B3.9 B
Slightly volatile

Pacific Fundamental Market Drivers

Cash And Short Term Investments389.9 M

Pacific Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pacific Biosciences Financial Statements

Pacific Biosciences stakeholders use historical fundamental indicators, such as Pacific Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Pacific Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pacific Biosciences' assets and liabilities are reflected in the revenues and expenses on Pacific Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pacific Biosciences of. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue13.9 M11.4 M
Total Revenue154 M79 M
Cost Of Revenue116.7 M70.2 M
Stock Based Compensation To Revenue 0.46  0.44 
Sales General And Administrative To Revenue 0.93  0.88 
Research And Ddevelopement To Revenue 0.88  0.83 
Capex To Revenue 0.04  0.04 
Revenue Per Share 0.56  0.50 
Ebit Per Revenue(2.31)(2.43)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
USOICredit Suisse X Links
ULTYTidal Trust II
CONYYieldMax N Option
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
How To Invest In Pacific
Details
Is Pacific Stock a good investment?
Details
What is Pacific Biosciences' Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Pacific Biosciences Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.74)
Revenue Per Share
0.542
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.32)
Return On Equity
(1.78)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY